ALiA BioTech at 2023 AACC Clinical Expo
We are delighted to share with you the successful exhibition of our ALiA platform for Point-Of-Care Testing at the 2023 AACC Clinical Expo in Anaheim, CA. Our technology has proven to be a valuable catalyst in disease diagnostics, generating significant interest from healthcare professionals and stakeholders who attended the event. At the expo, we had the opportunity to engage with partners and visitors, discussing the development and achievements of our ALiA platform. It’s always inspiring to receive such positive feedback and looking forward to continuing the conversation with our collaborators. As a company committed to advancing disease diagnostics, we firmly believe that our Point-Of-Care Testing technology can revolutionize healthcare delivery, particularly in areas where access to traditional laboratory testing is limited. We eagerly anticipate reconnecting with you in the future.
We will showcase our ALiA Platform at AACC Clinical Expo
5 MORE DAYS TO GO! Use promo code “34085E” to get a $35 discount off for the event ticket via https://lnkd.in/grnN9wAq From July 25th to 27th, our advanced Point of Care Testing platform – ALiA – will be showcased at the AACC Clinical Expo in Anaheim, CA. Please mark your calendar and visit us at booth 4520 to see how we adapt this advanced technology to drive healthcare innovation for the future.
Successful GBA Trip Explores Biotech Opportunities
We are joyous to announce the successful completion of our recent trip led by our CEO Kelvin Chiu and Director Wong Ming Yam to the Greater Bay Area (GBA), where we embarked on a journey to explore the burgeoning biotech industry. This two-day excursion proved to be an invaluable experience, providing us with insights into the region’s thriving ecosystem and fostering connections with key players in the field. During our visit, we had the privilege of engaging with some of the GBA’s leading biotech innovation hubs and unicorn companies. Our agenda was carefully curated to maximize our networking opportunities and collaborations. Our CEO @Kelvin Chiu and Director Wong Ming Yam played instrumental roles in facilitating meaningful discussions and forging partnerships with industry leaders. Their expertise and vision were evident as they navigated the dynamic landscape of the GBA, identifying potential synergies and exploring avenues for growth. We are delighted to have had the opportunity to showcase our organization’s capabilities and achievements during this trip. Through a series of interviews and presentations, we highlighted our groundbreaking research and innovative solutions regarding our ALiA platform – advanced solution of point of care testing; and commit to driving advancements in the biotech sector. The success of this trip has opened up new possibilities for us in the Greater Bay Area. We are excited to further explore collaborations, investments, and joint ventures with the region’s leading biotech companies. This journey has reinforced our belief in the immense potential of the GBA and its role as a global biotech hub. We extend our gratitude to the organizers, participants, and all those who supported us during this trip. We look forward to the future opportunities that will arise from our connections and experiences in the Greater Bay Area. #GreaterBayArea #BiotechIndustry #Collaborations #Innovation
Sanwa BioTech Showcases ALiA – Point of Care Testing Platform at Medical & Healthcare Fair 2023 in Hong Kong
We are pleased to report that we participated in the Medical & Healthcare Fair 2023, hosted by the Hong Kong Trade Development Council at the HKCEC from May 16 to 18, 2023. Our ALiA – Point of Care Testing Platform was showcased at Booth: 3E-E02 in the Hospital Equipment section of the Hong Kong Science and Technology Parks Pavilion, and it received a lot of attention from visitors. We are delighted to have had the opportunity to connect with healthcare professionals and demonstrate the value of our product – ALiA platform in the exhibition. As the pandemic subsides, we hope to see a resurgence of interest in the exhibition industry, allowing people to come together once again to share ideas and showcase the latest technologies and products.
Co-Check Supports Christian Action’s 3-Legged Charity Walk in Hong Kong
In May, Co-Check, a brand under the ALiA BioTech group, was delighted to support the “3-Legged Charity Walk” organized by Christian Action, a local non-governmental charitable organization in Hong Kong. Our colleagues were delighted to participate in the event with their family members to join in walking 3.5 kilometers up and down steep hills, all while being tied together in a 3-legged format. The event aimed to raise funds to support underprivileged children in need, and it was heartening to see everyone come together for such a great cause. Despite the physical challenge, our participants showed great enthusiasm and team spirit, making it a fun and memorable experience for all. As an organization committed to social responsibility, ALiA BioTech group was proud to be a part of this meaningful initiative. We believe that supporting local communities is crucial in creating a better future for all, and we will continue to seek out opportunities to give back and make a positive impact. We would like to extend our heartfelt thanks to Christian Action for organizing such a successful event and to our colleagues and their families for their participation and contribution. Together, we can continue to support those in need and build a brighter tomorrow.
Guest Speaker at CorporateTreasurer’s CTWeek HK 2023
CorporateTreasurer’s CTWeek HK 2023 took place on 25 April 2023 at JW Marriott Hotel Hong Kong, where top treasurers, CFOs and heads of finance from corporates across various industries gathered together to have open and deep-dive discussions on risk management, liquidity, opportunities in China’s Greater Bay Area, trends in supply chain finance, as well as forecasting tools that facilitate daily operations. Our CFO, Mr. Peter Ying, CGMA, CPA, LLM, was invited as one of the two guest speakers for the panel discussion – “Looking to Working Capital Management amid Economic Volatility”. Facing prolonged economic turmoil brought by global inflation, supply chain disruptions and rising costs of raw materials, Peter shared views and case examples on the application of strategies in navigating through supply chain uncertainties as well as effective means to manage supplier and vendor relationships to remain liquid and competitive during challenging times.